These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 19661336)

  • 1. Methylation mediated silencing of TMS1 in breast cancer and its potential contribution to docetaxel cytotoxicity.
    Gordian E; Ramachandran K; Singal R
    Anticancer Res; 2009 Aug; 29(8):3207-10. PubMed ID: 19661336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arsenic trioxide inhibits DNA methyltransferase and restores TMS1 gene expression in K562 cells.
    Li H; Wang Y; Xu W; Dong L; Guo Y; Bi K; Zhu C
    Acta Haematol; 2015; 133(1):18-25. PubMed ID: 24993472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demethylation of TMS1 gene sensitizes thyroid cancer cells to TRAIL-induced apoptosis.
    Siraj AK; Hussain AR; Al-Rasheed M; Ahmed M; Bavi P; Alsobhi SA; Al-Nuaim A; Uddin S; Al-Kuraya K
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E215-24. PubMed ID: 20926535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers.
    Conway KE; McConnell BB; Bowring CE; Donald CD; Warren ST; Vertino PM
    Cancer Res; 2000 Nov; 60(22):6236-42. PubMed ID: 11103776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of TMS1 in small cell, non small cell lung cancer and breast cancer.
    Virmani A; Rathi A; Sugio K; Sathyanarayana UG; Toyooka S; Kischel FC; Tonk V; Padar A; Takahashi T; Roth JA; Euhus DM; Minna JD; Gazdar AF
    Int J Cancer; 2003 Aug; 106(2):198-204. PubMed ID: 12800194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-mediated silencing of TMS1 in pancreatic cancer and its potential contribution to chemosensitivity.
    Ramachandran K; Miller H; Gordian E; Rocha-Lima C; Singal R
    Anticancer Res; 2010 Oct; 30(10):3919-25. PubMed ID: 21036703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of TMS1/ASC in death receptor signaling.
    Parsons MJ; Vertino PM
    Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A proapoptotic caspase recruitment domain protein gene, TMS1, is hypermethylated in human breast and gastric cancers.
    Moriai R; Tsuji N; Kobayashi D; Yagihashi A; Namiki Y; Takahashi H; Watanabe N
    Anticancer Res; 2002; 22(6C):4163-8. PubMed ID: 12553049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The methylation and mRNA expression of SLC5A8 and TMS1/ASC genes in human glioma].
    Jiang Z; Li XG; Hu J; Lu DR; Zhou W; Jiang YQ; Li CY
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(5):292-7. PubMed ID: 17456354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation-induced silencing of ASC/TMS1, a pro-apoptotic gene, is a late-stage event in colorectal cancer.
    Riojas MA; Guo M; Glöckner SC; Machida EO; Baylin SB; Ahuja N
    Cancer Biol Ther; 2007 Nov; 6(11):1710-6. PubMed ID: 17986858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma.
    Stone AR; Bobo W; Brat DJ; Devi NS; Van Meir EG; Vertino PM
    Am J Pathol; 2004 Oct; 165(4):1151-61. PubMed ID: 15466382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of methylation on expression of TMS1/ASC in human breast cancer cells.
    Levine JJ; Stimson-Crider KM; Vertino PM
    Oncogene; 2003 May; 22(22):3475-88. PubMed ID: 12776200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
    Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
    Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancer.
    Dong T; Zhang M; Dong Y; Herman JG; van Engeland M; Zhong G; Guo M
    Discov Med; 2015 Nov; 20(111):261-71. PubMed ID: 26645898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R
    Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-azacytidine reverses drug resistance in bladder cancer cells.
    Ramachandran K; Gordian E; Singal R
    Anticancer Res; 2011 Nov; 31(11):3757-66. PubMed ID: 22110197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
    Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
    Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation-mediated repression of GADD45alpha in prostate cancer and its role as a potential therapeutic target.
    Ramachandran K; Gopisetty G; Gordian E; Navarro L; Hader C; Reis IM; Schulz WA; Singal R
    Cancer Res; 2009 Feb; 69(4):1527-35. PubMed ID: 19190346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.